"Ukraine Pharmaceuticals & Healthcare Report Q4 2012" Now Available at Fast Market Research
BMI View: Foreign drugmakers operating in Ukraine need to be aware of the increasing likelihood of hryvnia devaluation. They must also be made aware that a little-known law adopted by the Verkhovna Rada in June hands the state much greater powers to regulate pricing on the Ukrainian market.
View full press release